[HTML][HTML] Nano-scale drug delivery systems for carboplatin: a comprehensive review

M Pourmadadi, MM Eshaghi, M Shaghaghi, SS Das… - OpenNano, 2023 - Elsevier
Carboplatin (CRBP) is a chemotherapeutic agent based on platinum that has applications in
the effective management of ovarian, testis, cervical, neck, head, and small cell lung cancer …

Recent advancement of nanomedicine-based targeted delivery for cervical cancer treatment

R Yadav, PP Das, S Sharma, S Sengupta, D Kumar… - Medical Oncology, 2023 - Springer
Cervical cancer is a huge worldwide health burden, impacting women in impoverished
nations in particular. Traditional therapeutic approaches, such as surgery, radiation therapy …

Recent Advancements in Metallic Au-and Ag-Based Chitosan Nanocomposite Derivatives for Enhanced Anticancer Drug Delivery

MA El-Meligy, EM Abd El-Monaem, AS Eltaweil… - Molecules, 2024 - mdpi.com
The rapid advancements in nanotechnology in the field of nanomedicine have the potential
to significantly enhance therapeutic strategies for cancer treatment. There is considerable …

[HTML][HTML] Recent advancements in the targeted delivery of Gemcitabine: Harnessing nanomedicine for enhanced cancer therapy

M Pourmadadi, A Aslani, D Hassan, A Sani, A Rahdar… - OpenNano, 2023 - Elsevier
Gemcitabine (GEM) is a chemotherapeutic drug widely used for treating pancreatic cancer
and other cancers. Despite its efficacy, GEM is associated with adverse side effects and …

[HTML][HTML] Enhancing cancer therapy: the potential of mercaptopurine-based nanomaterials for targeted drug delivery

M Pourmadadi, AR Ghohrodi, Z Savari, E Talebi… - Next …, 2023 - Elsevier
Mercaptopurine is a medication employed to treat autoimmune illnesses and cancer.
However, due to its poor solubility, quick metabolism, and possible side effects, it is not very …

[HTML][HTML] Lipid-based nanoparticles as drug delivery carriers for cancer therapy

I Waheed, A Ali, H Tabassum, N Khatoon… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
Cancer is a severe disease that results in death in all countries of the world. A nano-based
drug delivery approach is the best alternative, directly targeting cancer tumor cells with …

Internal stimuli-responsive nanocarriers for controlled anti-cancer drug release: A review

BB Shaik, NK Katari, SB Jonnalagadda - Therapeutic Delivery, 2023 - Taylor & Francis
Cancer disease is one of the most frequent life-threatening, with a high fatality rate
worldwide. However, recent immunotherapy studies in various tumours have yielded …

Peptide-Coated Polycaprolactone-Benzalkonium Chloride Nanocapsules for Targeted Drug Delivery to the Pancreatic β-Cell

J Collins, JM Barra, K Holcomb, A Ocampo… - ACS Applied Bio …, 2024 - ACS Publications
Targeting current therapies to treat or prevent the loss of pancreatic islet β-cells in Type 1
Diabetes (T1D) may provide improved efficacy and reduce off-target effects. Current efforts …

Ameliorating quercetin delivery in cancer therapy with polyvinyl alcohol/halloysite/starch nanocomposite

MA Badrloo, M Pourmadadi, M Abdouss… - Industrial Crops and …, 2024 - Elsevier
Challenges in cancer treatment can be overcome through the development of pH-
responsive drug delivery systems utilizing nanocarriers. This study reports the fabrication of …

[HTML][HTML] Nanoparticles in cancer diagnosis and treatment: Progress, challenges, and opportunities

N Rashidi, M Davidson, V Apostolopoulos… - Journal of Drug Delivery …, 2024 - Elsevier
Despite considerable progress in patient care, the global incidence of various cancer types
continues to rise. Developing safer and more efficient anti-cancer treatment approaches are …